Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms

…, G Nadkarni, E Pujadas, J Reidy, S Naymagon… - Gastroenterology, 2021 - Elsevier
Background & Aims Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary
manifestation of COVID-19, we investigated intestinal infection with SARS-CoV-2, its …

Gut microbiota density influences host physiology and is shaped by host and microbial factors

…, A Lucas, J Marion, E Maser, R Ungaro, S Naymagon… - Elife, 2019 - elifesciences.org
10.7554/eLife.40553.001 To identify factors that regulate gut microbiota density and the impact
of varied microbiota density on health, we assayed this fundamental ecosystem property …

Acute graft-versus-host disease of the gut: considerations for the gastroenterologist

S Naymagon, L Naymagon, SY Wong, HM Ko… - Nature Reviews …, 2017 - nature.com
Haematopoietic stem cell transplantation (HSCT) is central to the management of many
haematological disorders. A frequent complication of HSCT is acute graft-versus-host disease (…

A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States

A Tinsley, S Naymagon, AJ Trindade… - Journal of clinical …, 2013 - journals.lww.com
Background: Inflammatory bowel disease (IBD) patients are at an increased risk of thrombosis,
particularly when hospitalized. Several clinical practice guidelines now recommend …

Gastrointestinal involvement attenuates COVID-19 severity and mortality

…, G Nadkarni, E Pujadas, J Reidy, S Naymagon… - MedRxiv, 2020 - medrxiv.org
Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary manifestation of
coronavirus disease 2019 (COVID-19), we investigated intestinal infection with severe acute …

Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature

S Naymagon, RRP Warner, K Patel, N Harpaz… - Digestive diseases and …, 2010 - Springer
Background Microsphere radioembolization is a method of delivering radiation therapy
directly to tumors, thereby minimizing toxicity to adjacent structures. Despite the relatively high …

Accelerated infliximab dosing increases 30-day colectomy in hospitalized ulcerative colitis patients: a propensity score analysis

SC Shah, S Naymagon, HJ Panchal… - Inflammatory bowel …, 2018 - academic.oup.com
Background Standard outpatient induction dosing of infliximab (IFX) may not be effective in
hospitalized ulcerative colitis (UC) patients with higher inflammatory burden and colectomy …

Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center

A Tinsley, S Naymagon, LM Enomoto… - Journal of Crohn's …, 2013 - academic.oup.com
Background: Inflammatory bowel disease (IBD) patients are at increased risk for venous
thromboembolism (VTE) compared to the general population. Practice guidelines recommend …

The natural history, treatments, and outcomes of portal vein thrombosis in patients with inflammatory bowel disease

L Naymagon, D Tremblay, N Zubizarreta… - Inflammatory Bowel …, 2021 - academic.oup.com
Background Portal vein thrombosis (PVT) is a poorly described complication of inflammatory
bowel disease (IBD). We sought to better characterize presentations, compare treatments, …

Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors

A Tinsley, S Naymagon, B Mathers… - Scandinavian Journal …, 2015 - Taylor & Francis
Objective. Early readmission rates are becoming an integral measure of the quality of care
for hospitalized patients with chronic diseases. The incidence and predictors of early …